Get the Stockscreener App
97.92
2.76%
-2.78
After Hours:
98.06
0.14
+0.14%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $97.92, with a volume of 15.31M.
It is down -2.76% in the last 24 hours and down -2.14% over the past month.
See More
Previous Close:
$100.70
Open:
$100.47
24h Volume:
15.31M
Relative Volume:
1.52
Market Cap:
$251.88B
Revenue:
$63.17B
Net Income/Loss:
$12.15B
P/E Ratio:
20.53
EPS:
4.77
Net Cash Flow:
$14.84B
1W Performance:
-1.34%
1M Performance:
-2.14%
6M Performance:
-22.22%
1Y Performance:
-17.11%
1-Day Range:
$97.92
$100.47
1-Week Range:
$97.92
$101.49
52-Week Range:
$94.48
$134.63
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
Compare MRK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
97.92 | 251.88B | 63.17B | 12.15B | 14.84B | 4.77 |
|
LLY
Lilly Eli Co
|
725.72 | 689.73B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
78.69 | 349.44B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
147.03 | 344.63B | 87.70B | 14.68B | 19.03B | 6.05 |
|
ABBV
Abbvie Inc
|
171.56 | 303.17B | 55.53B | 5.12B | 15.62B | 2.88 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | Truist | Buy → Hold |
| Dec-20-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Buy |
| Dec-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Merck: 3x Pipeline And Undervaluation Make It A Buy (NYSE:MRK) - Seeking Alpha
Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey
AHL Investment Management Inc. Invests $269,000 in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Annex Advisory Services LLC Trims Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Brady Martz Wealth Solutions LLC Acquires Shares of 17,939 Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Ameritas Advisory Services LLC - MarketBeat
Jim Cramer on Merck & Co., Inc. (MRK): ‘Right Now, The Stock’s Well-ensconced A Few Points Around 52-week Low’ - Insider Monkey
Folger Nolan Fleming Douglas Capital Management Inc. Has $6.91 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Wealth Alliance Advisory Group LLC Reduces Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Kera Capital Partners Inc. Purchases New Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Jackson Square Capital LLC Sells 15,684 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
HB Wealth Management LLC Increases Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Integrated Investment Consultants LLC Has $62.33 Million Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Holdings Lifted by Merit Financial Group LLC - MarketBeat
Arkadios Wealth Advisors Decreases Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Is Moderna Stock a Buy? - The Motley Fool
How Is Merck's Stock Performance Compared to Other Pharmaceuticals Stocks? - MSN
Is Merck & Co., Inc. (MRK) the Best Cheap Stock to Buy for 2025? - Insider Monkey
Exclusive: Kennedy played key role in Gardasil vaccine case against Merck - Reuters
Householder Group Estate & Retirement Specialist LLC Sells 4,613 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Relyea Zuckerberg Hanson LLC Purchases 3,131 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Hennessy Advisors Inc. Increases Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Bought by Carnegie Investment Counsel - MarketBeat
Merck Stock Price | MRK Stock Quote, News, and History - Markets Insider
Purdue teams with Lilly, Merck to launch pharma manufacturing initiative - Inside INdiana Business
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Guggenheim cuts Merck stock target, retains Buy on revised estimates - MSN
Drug Discovery Market Generated Opportunities, Future Scope by 2031 | Pfizer Inc., GlaxoSmithKline LLC, Merck - EIN News
KMG Fiduciary Partners LLC Acquires 14,161 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Empirical Asset Management LLC Raises Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Eagle Rock Investment Company LLC Sells 13,523 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stake Lessened by Salvus Wealth Management LLC - MarketBeat
Tallon Kerry Patrick Acquires Shares of 3,679 Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Gateway Investment Advisers LLC - MarketBeat
7MM Type 1 Diabetes Market Drug Forecast and Market Analysis 2023-2024 & 2033: Value to Reach $9.91 Billion - GlobeNewswire Inc.
Merck Defends 3rd Circ. Win In Mumps Vaccine Antitrust Case - Law360
Godsey & Gibb Inc. Acquires 9,571 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and Earnings Conference Call Feb. 4 - Business Wire
Campbell Newman Asset Management Inc. Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Wolff Wiese Magana LLC Acquires 4,633 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Founders Grove Wealth Partners LLC Buys New Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Assenagon Asset Management S.A. Sells 1,440,399 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Jim Cramer on Merck & Co., Inc. (MRK): ‘Down Very Badly’ - Insider Monkey
Who Are Pfizer's (PFE) Main Competitors? - Investopedia
Merck & Co., Inc. (NYSE:MRK) Stock Holdings Trimmed by Park Avenue Securities LLC - MarketBeat
Price Over Earnings Overview: Merck & Co - Benzinga
Pines Wealth Management LLC Buys New Shares in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Rockland Trust Co. Buys 30,562 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Horizon Bancorp Inc. IN Buys 9,938 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by AdvisorNet Financial Inc - MarketBeat
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):